OEM Factory for Amoxicillin Trihydrate Powder - Ceftriaxone for inj. – KeMing Medicines Detail:
| FOB Price | Inquiry |
| Min.Order Quantity | 50,000 Vials |
| Supply Ability | 9,000,000 bottles/Month |
| Port | Shanghai |
| Payment Terms | T/T in advance |
| Product Detail | |
| Product name | Ceftriaxone for inj. |
| Specification | 1g+10ml |
| Description | A white, crystalline powder |
| Standard | BP |
| Package | 1Vials+1 ampoule/box |
| Transportation | Ocean,Land,Air |
| Certificate | GMP |
| Price | Inquiry |
| Quality guaranteeperiod | for 36 months |
| Product Description | [Primary indication] Third generation cephalosporin Used for treating neonatal meningitis and sepsis caused by susceptible gram negative organisms(E Coli,Klebsiella,H flu). It competes with bilirubin for binding sites on albumin. |
Product detail pictures:
Related Product Guide:
Disease, Doctors, Drugs and Vitamins!
Prescription Drugs Can Lead to Vitamin and Mineral Deficiencies
To regularly increase the management program by virtue from the rule of "sincerely, good religion and high quality are the base of enterprise development", we greatly absorb the essence of linked products internationally, and constantly produce new goods to satisfy the calls for of shoppers for OEM Factory for Amoxicillin Trihydrate Powder - Ceftriaxone for inj. – KeMing Medicines, The product will supply to all over the world, such as: Qatar, Indonesia, Mexico, With the superior and exceptional service, we are well developed along with our customers. Expertise and know-how ensure that we are always enjoying the trust from our customers in our business activities. "Quality", "honesty" and "service" is our principle. Our loyalty and commitments remain respectfully at your service. Contact Us Today For further information, contact us now.
By Elma from Bahamas - 2018.11.06 10:04
The factory has advanced equipment, experienced staffs and good management level, so product quality had assurance, this cooperation is very relaxed and happy!
By Kristin from Zurich - 2017.01.11 17:15
